MYLISSA PERSONS: Open Payments
NPI 1992132328 · PORT CHARLOTTE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,732 in 97 payments from 17 companies in 2025. Trend: 2023 $1,711 · 2024 $1,644 · 2025 $1,732
Food & beverage: $1,732
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $342 |
| PFIZER INC. | 10 | $238 |
| Novo Nordisk Inc | 10 | $175 |
| Amgen Inc. | 12 | $173 |
| GlaxoSmithKline, LLC. | 18 | $159 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $135 |
| Esperion Therapeutics, Inc. | 7 | $130 |
| Astellas Pharma US Inc | 5 | $113 |
| IBSA Pharma Inc. | 3 | $64 |
| Lilly USA, LLC | 2 | $41 |
Products named: QULIPTA, CAPLYTA, NEXLETOL, NURTEC ODT, Veozah, TRELEGY ELLIPTA, EVENITY, ELIQUIS.
Industry payments across FL — which companies pay providers there.
